Asset Comparison and Correlation

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 7, 2012.

RALEIGH, NC, Feb 07, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/zigman/87125/quotes/nls/slxp SLXP -0.25% today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug ...

Salix Pharmaceuticals (NASDAQ:SLXP) shares have crossed bullishly above their 10-day moving average of $46.89 on a volume of 132K shares.

TAMPA, Fla.--(EON: Enhanced Online News)--Neutra Corp. (OTCBB: NTRR), an emerging nutraceuticals provider, is excited to announce that clinical trials are now underway on its debut weight-loss supplement, Pure Plus.

TAMPA, Fla.--(BUSINESS WIRE)--Neutra Corp. (OTCBB: NTRR), an emerging nutraceuticals provider, is excited to announce that clinical trials are now underway on its debut weight-loss supplement, Pure Plus.

By Business Wire 02/06/12 - 05:00 AM EST Neutra Corp. (OTCBB: NTRR), an emerging nutraceuticals provider, expects to begin clinical trials of its eagerly anticipated new all-natural weight-loss supplement as early as this week when the company's first ...

The stock markets of late are in a slow paced uptrend in the last 30 days and the stocks with bright prospects and compelling valuations are being picked by shrewd investors, the riskier stocks are still losing their value.